Status:
RECRUITING
Thermovision-controlled Lumbar Sympathetic Blockade in Chronic Limb-threatening Ischemia Treatment
Lead Sponsor:
Europainclinics z.ú.
Collaborating Sponsors:
Slovak Academy of Sciences
Conditions:
Chronic Limb-Threatening Ischemia
Eligibility:
All Genders
20-80 years
Phase:
NA
Brief Summary
Thermovision-controlled lumbar sympathetic blockade in chronic limb-threatening ischemia treatment
Detailed Description
Chronic limb-threatening ischemia (CLTI), the end-stage of lower extremity artery disease (LEAD), occurs with growing prevalence around the globe and is associated with increased healthcare costs. CLT...
Eligibility Criteria
Inclusion
- Chronic limb-threatening ischemia-Patients with chronic leg pain for at least 6 months with intensity (VAS \>=5)
- those who (only if a signature was obtainable), or whose legal guardian,fully understood the clinical trial -details and signed the informed consent form
Exclusion
- Chronic Venous Insufficiency
- women with positive a pregnancy tests before the trial or who planned to become pregnant within the following 3 years
- other patients viewed as inappropriate by the staff
- disagreement with participation in the study
Key Trial Info
Start Date :
October 22 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06111599
Start Date
October 22 2023
End Date
August 31 2026
Last Update
November 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Europainclinics
Košice, Slovakia, 04011